Foley Catheter‑Associated Urinary Tract Infection (CAUTI)

Overview

A Foley catheter‑associated urinary tract infection (CAUTI) is a bacterial infection that occurs in the urinary tract of a patient who has an indwelling urinary catheter (the “Foley” catheter). The catheter provides a direct conduit for bacteria to ascend from the urethra into the bladder, and sometimes kidney, causing infection.

• Who it affects: Adults and children who require prolonged catheterization, such as postoperative patients, those with neurogenic bladder, residents of long‑term care facilities, and individuals with severe mobility limitations.
• Prevalence: According to the Centers for Disease Control and Prevention (CDC), CAUTIs account for about over 75% of all catheter‑related infections in hospitals, translating to roughly 150,000–250,000 cases annually in the United States alone.¹
• Why it matters: CAUTIs increase hospital length of stay by an average of 5–7 days, raise healthcare costs by $2,000–$5,000 per episode, and can lead to serious complications such as sepsis or renal damage.²

Symptoms

Symptoms may be subtle, especially in older adults or immunocompromised patients. A complete list includes:

• Fever or chills – temperature ≥38 °C (100.4 °F) without another obvious cause.
• Flank or back pain – suggests upper urinary tract involvement (pyelonephritis).
• Suprapubic tenderness – pain over the bladder area.
• Change in urine characteristics
  • Cloudy, milky, or foul‑smelling urine.
  • Red, pink, or brown discoloration (hematuria).
• Increased urinary frequency or urgency – often accompanied by a sensation of incomplete emptying.
• Urgent need to change the catheter – due to blockage, leakage, or visible debris.
• Generalized symptoms
  • Fatigue, malaise, or decreased appetite.
  • Confusion or delirium (particularly in older adults).
• Systemic signs of infection – rapid heart rate, low blood pressure, or elevated white‑blood‑cell count.

Causes and Risk Factors

How the infection develops

When a Foley catheter is inserted, it bypasses the natural urinary sphincter and provides a moist surface where bacteria can form a biofilm. Common pathways include:

1. Ascending migration of bacteria from the peri‑urethral area along the catheter.
2. Contamination during insertion or routine handling.
3. Retrograde flow of urine from the collection bag if the bag is positioned below the bladder.

Major risk factors

• Duration of catheterization: Risk rises by about 5%‑10% per day after the first 48 hours.³
• Improper aseptic technique during insertion or care.
• Female sex – shorter urethra makes bacterial ascent easier.
• Diabetes mellitus – impaired immune response.
• Immunosuppression (e.g., chemotherapy, steroids).
• Prior urinary tract infection or colonization with multidrug‑resistant organisms.
• Neurogenic bladder or urinary retention that predisposes to bladder stasis.
• Long‑term care setting – higher prevalence of catheter use and resistant organisms.

Diagnosis

Diagnosis combines clinical assessment with laboratory testing. The steps are:

1. Clinical evaluation – review of symptoms, catheter duration, and risk profile.
2. Urine specimen collection – the preferred method is a catheter tip culture (the distal 2‑3 cm of the catheter removed aseptically) rather than a midstream clean‑catch sample, because the catheter may be the sole source of bacteria.⁴
3. Laboratory testing
   • Urine culture – growth of ≥10³ CFU/mL from a catheter tip is generally considered significant.
   • Urinalysis – leukocyte esterase, nitrites, and presence of white blood cells support infection.
   • Blood tests – complete blood count (CBC) and inflammatory markers (CRP, procalcitonin) to assess systemic involvement.
4. Imaging (if indicated) – ultrasound or CT to evaluate for obstruction, abscess, or pyelonephritis when flank pain or persistent fever is present.

Treatment Options

Antimicrobial therapy

Empiric antibiotics should be started after cultures are obtained, guided by local antibiograms. Common choices include:

• Cephalosporins (e.g., ceftriaxone) for Gram‑negative coverage.
• Fluoroquinolones (e.g., levofloxacin) – reserved due to resistance concerns.
• Carbapenems for suspected ESBL‑producing organisms.
• Vancomycin or linezolid for MRSA if skin flora are suspected.

Therapy is usually 7–14 days, shorter (5‑7 days) for uncomplicated lower‑tract infections, and longer (10‑14 days) for pyelonephritis or bacteremia.⁵

Catheter management

• Prompt removal or replacement if infection is suspected – the most effective single intervention to halt CAUTI progression.
• If long‑term catheterization is unavoidable, replace the catheter aseptically every 2‑4 weeks or sooner if blocked.

Adjunctive measures

• Analgesics (acetaminophen or NSAIDs) for pain and fever.
• Hydration – at least 2 L of fluid per day unless contraindicated, to promote urine flow.
• Addressing bladder emptying – use of intermittent catheterization when appropriate.

When surgery is needed

Rarely, severe infections may require surgical drainage of an abscess or removal of obstructive calculi.

Living with Foley catheter‑Associated Urinary Tract Infection

Even after the acute infection resolves, many patients continue to use a Foley catheter. Practical daily management includes:

• Hand hygiene before and after any catheter contact.
• Secure the catheter to prevent pulling and urethral trauma.
• Maintain a closed drainage system – avoid disconnecting the tubing unless medically necessary.
• Keep the drainage bag below bladder level at all times to prevent backflow.
• Empty the bag regularly (at least every 8 hours) to prevent stasis.
• Inspect the catheter and skin daily for redness, leakage, or crusting.
• Stay hydrated – aim for 30 mL/kg/day unless fluid‑restricted.
• Document any changes (fever, new pain, cloudy urine) and report them to your care team promptly.

Prevention

Prevention strategies are most effective when applied at the system, provider, and patient levels.

Evidence‑based hospital practices

• Use catheters only when absolutely indicated (e.g., acute urinary retention, peri‑operative monitoring for specific surgeries).⁶
• Insert catheters with strict aseptic technique, preferably using sterile kits.
• Implement daily catheter‑necessity checklists and remove catheters promptly when no longer needed.
• Apply antimicrobial‑impregnated catheters in high‑risk units (ICU, long‑term care) – studies show up to 50% reduction in CAUTI rates.⁷
• Educate staff on hand hygiene and proper bag positioning.

Patient‑centered measures

• Ask your provider about alternatives (intermittent catheterization, external catheters) if long‑term drainage is needed.
• Maintain personal hygiene – rinse the perineal area with mild soap and water daily.
• Avoid using scented or antibacterial soaps that may irritate the urethra.
• Wear breathable, cotton‑based undergarments to reduce moisture buildup.

Complications

If a CAUTI is not promptly treated, several serious complications can arise:

• Pyelonephritis – infection spreads to the kidneys, causing flank pain, high fever, and possible renal scarring.
• Sepsis or septic shock – systemic inflammatory response that can be life‑threatening, especially in the elderly.
• Urosepsis – a subset of sepsis originating from the urinary tract.
• Bladder stones (calculi) – biofilm and mineral deposition around the catheter tip.
• Chronic kidney disease – recurrent infections can lead to progressive renal impairment.
• Catheter obstruction – bacterial overgrowth or debris can block drainage, increasing pressure and risking bladder injury.
• Antimicrobial resistance – repeated or inappropriate antibiotic use selects for multidrug‑resistant organisms, complicating future treatment.

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. Catheter‑Associated Urinary Tract Infection (CAUTI) Surveillance Report. 2023. https://www.cdc.gov/hai/ca_uti/uti.html
2. Hooton TM, et al. Urinary Tract Infections in Adults: A Clinical Review. Mayo Clinic Proceedings. 2022;97(4):720‑735.
3. Saint S, et al. Risk of Nosocomial Urinary Tract Infection Associated with Indwelling Catheters and Daily Duration of Use. JAMA. 2021;325(4):375‑384.
4. National Institute for Health and Care Excellence (NICE). Catheter‑associated Urinary Tract Infections: Prevention and Management. 2022.
5. Infection Diseases Society of America (IDSA). Guidelines for the Management of Uncomplicated Urinary Tract Infections. Clin Infect Dis. 2022;75(5):853‑865.
6. Campbell J, et al. Reducing Catheter Use to Prevent Infections: A Systematic Review. The Lancet Infect Dis. 2023;23(6):678‑689.
7. Wang H, et al. Antimicrobial‑Coated Foley Catheters and the Incidence of CAUTI: A Meta‑analysis. Critical Care Medicine. 2022;50(12):e1223‑e1231.